<DOC>
	<DOC>NCT02404493</DOC>
	<brief_summary>The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.</brief_summary>
	<brief_title>Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin</brief_title>
	<detailed_description>50 infants and toddlers will be enrolled in this study to yield 40 completed subjects, 30 babies in the active treatment group and 10 babies in the positive control group. Infants and toddlers aged 6 to 47 months inclusive will receive either a prescription or non-marketed investigational product for the treatment of eczema. Caregivers will be asked to stop use of prescription eczema treatments one week before the start of the study and during the study. Caregivers will apply study product to babies as indicated for 14 days to affected areas. Subject caregivers will record treatment use in a daily diary and complete questionnaires. A dermatologist will examine and score the babies eczema and symptoms. Skin moisture levels will also be tested.</detailed_description>
	<mesh_term>Decanoic acid</mesh_term>
	<criteria>1. Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates) 2. Male or female of any race or ethnicity, 6 months to 47 months of age; 3. Diagnosed as having eczema 4. Willing to stop use of all nonassigned moisturizers and/or creams for the entire duration of the study 5. Child must have bedtime/sleep issues due to their dry, itchy skin 1. Use of a therapeutic (overthecounter or prescription) body wash that contains an active ingredient for eczema 2. Participation in any clinical study within 30 days of Visit 1 3. Active infection of any type at the start of the study 4. Diagnosed as having severe eczema 5. Atopic Dermatitis requiring systemic, superpotent (Class I) or potent (Class II or III) topical corticosteroids 6. Child wakes up 3 or more times during the night 7. Child is awake more than 60 minutes during the night 8. Child sleeps for less than a total of 9 hours (during the day or night) 9. Child requires greater than 2.0 mg per day of inhaled or intranasal corticosteroids</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>47 Months</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>